Please provide your email address to receive an email when new articles are posted on . There has been quite an evolution of IOLs since their inception. In the era of refractive cataract surgery, ...
Please provide your email address to receive an email when new articles are posted on . Ophthalmologists have been searching for effective ways to address presbyopia for many decades, particularly ...
Dec. 12, 2003 — Editor's Note: On Nov. 14, Eyeonics, Inc., received U.S. Food and Drug Administration (FDA) approval to market the first accommodating intraocular lens (Crystalens) that allows ...
Bausch & Lomb has introduced Crystalens AO, an aberration free accommodating intraocular lens with aspheric optics, according to a Bausch & Lomb news release. The Crystalens AO has prolate aspheric ...
PowerVision, Inc., a private company developing an accommodating intraocular lens, today announced the closing of the first tranche of its Series D funding round with participation from existing ...
LensGen, a California-based developer of intraocular lenses (IOL) for the treatment of presbyopia and cataracts, has announced the release of $11 million in Series A funding. The funds are part of the ...
New types of intraocular lens, femtosecond laser, collagen cross-linking, and microinvasive glaucoma surgery (MIGS) will feature prominently at the upcoming American Society of Cataract and Refractive ...
SAN FRANCISCO--For most people, the need to wear eyeglasses to read is an inevitable part of aging. The eye's natural lens hardens and loses its ability to change shape, making it more difficult to ...
IRVINE, Calif.--(BUSINESS WIRE)--April 12, 2004--Medennium Inc. of Irvine, a leader in innovative solutions for ophthalmology, announced today that it has retained GD Services Inc. of Newport Beach, ...
Bausch + Lomb has announced it is extending the rebate program for patients who have the company’s Crystalens accommodating intraocular lens implanted before March 31, 2011. Patients will be eligible ...
Abbott, based in Abbott Park, Ill., acquired Irvine, Calif.-based Visiogen for $400 million in cash, expanding the company’s vision care portfolio, according to an Abbott news release. As part of the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results